Also this trial has no relevance to sales. It's purely to support the use of this product and will just add ammunition to the sales force once it is done.
No reason to fret.
- Forums
- ASX - By Stock
- Ann: FDA feedback on Pivotal Protocol
Also this trial has no relevance to sales. It's purely to...
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.58 |
Change
-0.095(3.56%) |
Mkt cap ! $1.753B |
Open | High | Low | Value | Volume |
$2.62 | $2.62 | $2.53 | $2.622M | 1.022M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 7061 | $2.57 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.58 | 44003 | 45 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 4685 | 2.570 |
27 | 63128 | 2.560 |
17 | 28048 | 2.550 |
21 | 69023 | 2.540 |
13 | 23108 | 2.530 |
Price($) | Vol. | No. |
---|---|---|
2.580 | 44169 | 46 |
2.590 | 56350 | 21 |
2.600 | 16329 | 14 |
2.610 | 66289 | 13 |
2.620 | 52360 | 8 |
Last trade - 13.08pm 25/07/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |